Discover
Educators
90 Episodes
Reverse
What It Takes is a podcast series featuring intimate, revealing conversations with towering figures in almost every field: music, science, sports, politics, film, technology, literature, the military and social justice. These rare interviews have been recorded over the past 25 years by The Academy of Achievement. They offer the life stories and reflections of people who have had a huge impact on the world, and insights you can apply to your own life. Subscribe to the What It Takes podcast series at iTunes.com/WhatItTakes
Since the 1990s, Roger Tsien has revolutionized the fields of cell biology and neurobiology by designing fluorescent protein molecules to illuminate biochemical processes. The green fluorescent protein GFP, which occurs naturally in the jellyfish Aequorea Victoria, has been used in biochemical research since the 1960s, but work with GFP was long constrained by its single color and unstable light. Tsien was awarded the 2008 Nobel Prize in Chemistry for developing a kaleidoscopic array of fluorescent molecules. When attached to other, less visible proteins, they enable scientists to track multiple biochemical processes simultaneously. As a teenager, the New York-born Tsien won first prize in the Westinghouse Science Talent Search. He graduated summa cum laude from Harvard and earned his Ph.D. in physiology at Cambridge University. Since 1989 he has been a professor at the University of California, San Diego, where he is an investigator of the Howard Hughes Medical Institute. In 1994, Tsien identified a single-point mutation of the natural GFP molecule that produced a more stable and intense light, with greater variability in color, a discovery he reported in the Journal Nature. Over the next decade, he produced variants of GFP in a full spectrum of colors. His molecules are used in surgery and in Alzheimer's and cancer research. He was a co-founder of Aurora Biosciences Corporation, later acquired by Vertex Pharmaceuticals for roughly $600 million. In this podcast, recorded at the Top of the Hay, Hay-Adams Hotel, in Washington, D.C., during the 2012 International Achievement Summit, Dr. Tsien discusses the role of motivation and creativity in relation to his work building artificial molecules.
Salman Khan founded the nonprofit Khan Academy with
the mission of providing free, high-quality education for “anyone, anywhere” in the
world. Born in Metairie, Louisiana, to immigrant parents from India and
Bangladesh, Khan graduated from MIT in 1998 with three degrees: one bachelor of
science in mathematics; another in electrical engineering and computer science;
and a master's in electrical engineering.
After MIT, Khan worked in Silicon Valley at the height of the tech boom. When the
bubble burst in 2000, he enrolled in Harvard Business School. After earning a
master's in business administration, he became an analyst at a Boston-based
hedge fund. The following year, as a side project, he began tutoring a young
cousin in math, communicating by phone and using an interactive notepad. When
others expressed interest in this method of instruction, he began posting videos of
his hand-scribbled tutorials on YouTube. Demand took off, and in 2009 he quit his
day job to commit himself fully to the not-for-profit Khan Academy.
In October 2010, Khan was listed in Fortune’s annual “40 Under 40,” which
recognizes business’s hottest rising stars, as well as Fast Company’s list of the
“100 Most Creative People in Business.” He was recently profiled by 60 Minutes
and recognized by Time magazine as one of the 100 most influential people in the
world. His first book, The One World Schoolhouse: Education Reimagined, was
published this month.
Robert S. Langer is heralded as one of the most prolific inventors in the history of medicine, the father of controlled drug release and tissue engineering. His research laboratory at MIT is the largest biomedical engineering lab in the world, maintaining about $10 million in annual grants and over 100 researchers. His discoveries have saved countless lives and launched a $20 billion-a-year industry. Every year, 6,200 Americans die awaiting transplants of organs like the liver, heart and lung, but Robert Langer is creating a future where spare organs can be grown in the laboratory. IN addition to his endowed chair at MIT, he is a faculty member of the Harvard-MIT Division of Health Sciences and Technology and the David H. Koch Institute for Integrative Cancer Research. In this podcast, recorded at the Top of the Hay, in Washington D.C.'s Hay-Adams Hotel, during the 2012 International Achievement Summit, he reflect on his career in science, the importance of the patent system, and his ideas about the treatment of cancer.
Robert S. Langer is heralded as one of the most prolific inventors in the history of medicine, the father of controlled drug release and tissue engineering. His research laboratory at MIT is the largest biomedical engineering lab in the world, maintaining about $10 million in annual grants and over 100 researchers. His discoveries have saved countless lives and launched a $20 billion-a-year industry. Every year, 6,200 Americans die awaiting transplants of organs like the liver, heart and lung, but Robert Langer is creating a future where spare organs can be grown in the laboratory. IN addition to his endowed chair at MIT, he is a faculty member of the Harvard-MIT Division of Health Sciences and Technology and the David H. Koch Institute for Integrative Cancer Research. In this podcast, recorded at the Top of the Hay, in Washington D.C.'s Hay-Adams Hotel, during the 2012 International Achievement Summit, he reflect on his career in science, the importance of the patent system, and his ideas about the treatment of cancer.







